NasdaqGS:PRVAHealthcare
Privia Health Group (PRVA) Valuation In Focus After CFO Share Sale And Post Earnings Analyst Updates
Insider selling and analyst updates put Privia Health Group (PRVA) in focus
Privia Health Group (PRVA) is back on investor radar after Chief Financial Officer David Mountcastle sold 5,566 shares, followed by a fresh round of analyst updates after the company’s Q4 earnings release.
See our latest analysis for Privia Health Group.
At a share price of $22.38, Privia Health Group has seen short term momentum pick up, with a 1 day share price return of 3.66% and a 7 day share price return of...